Compound Detail
CHEMBL5410609
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1cc(N)nc(-c2c(Cl)cc3c(N4CC5CCC(C4)N5)nc(OC[C@@]45CCCN4C[C@H](F)C5)nc3c2F)c1C(F)(F)F
Basic Information
| ChEMBL ID | CHEMBL5410609 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YODMLRHFGATDGU-OGBBLICMSA-N |
1
Targets
3
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
624.1
MW (Da)
5.29
ALogP
8
HBA
2
HBD
92.4
PSA (Ų)
0.37
QED
2
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 8.68
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| GTPase KRas CHEMBL2189121 | IC50 | 8.68 | 7.5167 | 2.1 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| GTPase KRas | IC50 | = | 2.1 | nM | 8.68 | Inhibition of GDP-bound biotinylated-KRAS G12D mutant (1 to 169 residues) (unkno... | 37849557 |
| GTPase KRas | IC50 | = | 89.9 | nM | 7.05 | Inhibition of KRAS G12D mutant in human ASPC1 cells assessed as reduction in ERK... | 37849557 |
| GTPase KRas | IC50 | = | 153.0 | nM | 6.82 | Inhibition of wild-type GDP-bound biotinylated-KRAS (unknown origin) assessed as... | 37849557 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37849557 | 10.1021/acsmedchemlett.3c00245 | GTPase KRas | 5 |
Data from ChEMBL 36 via Core Engine